A novel biological activity of praziquantel requiring voltage-operated Ca2+ channel beta subunits: subversion of flatworm regenerative polarity.
<h4>Background</h4>Approximately 200 million people worldwide harbour parasitic flatworm infections that cause schistosomiasis. A single drug-praziquantel (PZQ)-has served as the mainstay pharmacotherapy for schistosome infections since the 1980s. However, the relevant in vivo target(s)...
Guardado en:
Autores principales: | Taisaku Nogi, Dan Zhang, John D Chan, Jonathan S Marchant |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/54ba41af79114d84ae2c8babca92ef9a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of novel modulators of a schistosome transient receptor potential channel targeted by praziquantel.
por: Evgeny G Chulkov, et al.
Publicado: (2021) -
Identification of novel modulators of a schistosome transient receptor potential channel targeted by praziquantel
por: Evgeny G. Chulkov, et al.
Publicado: (2021) -
Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials.
por: Dimitrios K Matthaiou, et al.
Publicado: (2008) -
Metabolomics reveal alterations in arachidonic acid metabolism in Schistosoma mekongi after exposure to praziquantel.
por: Peerut Chienwichai, et al.
Publicado: (2021) -
Efficacy and safety of praziquantel, tribendimidine and mebendazole in patients with co-infection of Clonorchis sinensis and other helminths.
por: Li-Li Xu, et al.
Publicado: (2014)